A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Celecoxib Impurity 25 | CAS 877-67-8 - Request Quote

Picture of Celecoxib Impurity 25

Celecoxib Impurity 25

SZ CAT No:SZ-C005037
CAS No
877-67-8
Mol.F.
C6H8N2O3S
Mol.Wt.
188.2
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Celecoxib Impurity 25 is chemically 4-(Hydroxyamino)benzenesulfonamide. Celecoxib Impurity 25 is supplied with detailed characterization data compliant with regulatory guideline. Celecoxib Impurity 25 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Celecoxib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 877-67-8

Purchase 877-67-8

Order 877-67-8

Enquire 877-67-8

price of 877-67-8

877-67-8 Supplier

877-67-8 Manufacturer

877-67-8 Exporter

buy high quality Celecoxib Impurity 25

Purchase Celecoxib Impurity 25

Celecoxib Impurity 25 suppliers

Celecoxib Impurity 25 manufacturers

Celecoxib Impurity 25 price

Order Celecoxib Impurity 25

Enquire Celecoxib Impurity 25

Celecoxib Impurity 25 cost

Celecoxib Impurity 25 Supplier

Celecoxib Impurity 25 Distributor

Celecoxib Impurity 25 for Method Validation

Celecoxib Reference Standard

Celecoxib Impurity 25 for ANDA Filing

Celecoxib Impurity 25 for Forced Degradation Studies

Celecoxib Impurity 25 Identification Standards

Celecoxib Impurity 25 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,